Ghisallo Capital Management LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ghisallo Capital Management LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$5,097,500
+9.4%
125,0000.0%0.61%
-45.6%
Q1 2023$4,658,750
-46.6%
125,000
-50.0%
1.12%
-27.9%
Q4 2022$8,722,500
+225.1%
250,000
+1150.0%
1.55%
+1422.5%
Q3 2021$2,683,000
-52.7%
20,000
-42.9%
0.10%
-52.6%
Q2 2021$5,667,00035,0000.22%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders